Single-use Bioreactors Market - Global Forecast to 2029
| 出版年月 | 2024年8月 |
| ページ数 | 443 |
| 図表数 | 630 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global single-use bioreactors market is projected to reach USD 9.1 billion by 2029 from USD 4.4 billion in 2024, at a CAGR of 15.4% during the forecast period of 2024 to 2029.
世界のシングルユースバイオリアクター市場は、2024年から2029年の予測期間中にCAGR 15.4%で、2024年の44億米ドルから2029年までに91億米ドルに達すると予測されています。
The advantages of SUBs above conventional bioreactors drive the market expansion. Made of premium plastic materials, SUBs are intended for single-use use hence sterilizing and cleaning between batches is not necessary. This lowers cross-contamination risk greatly and increases operational effectiveness. The rise of SUBs as a fundamental technology inside the single-use bioprocessing sector has transformed the development and manufacturing of biopharmaceutical products. Their benefits over traditional stainless-steel bioreactors make them the preferred option for biopharmaceutical companies, CMOs, and research facilities.
“The pharmaceutical & biotechnology companies segment accounted for the largest share by end user in 2023.”
In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share by end user in the global single-use bioreactors market. The growth in this market can be attributed to rising R&D initiatives by pharmaceutical, biopharmaceutical, and biotechnology companies and the increased production of biologics and biosimilars. Moreover, the widespread use of SUBs among pharmaceutical and biotechnology companies across established and developed markets, such as North America and Europe, and the rising approvals of biologics and biosimilars in these regions are the major factors supporting the growth of this end-user segment.
“The US has continued to dominate the single-use bioreactors market during the forecast period of 2024-2029.”
The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Pharmaceutical companies in the US are actively participating in developing biologics and biosimilars and increasingly utilizing single-use bioreactors, which offers less turnaround time, has low installation costs, and is energy-efficient. These factors support the growth of the US single-use bioreactors market. Furthermore, the expiry of many biologics contributes to the growth of the biopharmaceutical industry in the US. The US accounts for the highest number of patents due for expiration. Several strategies are being undertaken by pharmaceutical companies in the US, such as the development of biosimilars, new formulations for patented drugs, new routes of administration for known drugs, and combinations for extending drug commercial lifecycles, which will result in an increase in biopharmaceutical R&D and new generations of biologic medicines. As single-use bioreactors are associated with a low risk of contamination and low implementation costs, their adoption in biopharmaceutical companies for R&D is expected to increase. These factors are supporting the growth of the single-use bioreactors market in the country.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
- Sartorius AG (Germany)
- Danaher Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- Avantor, Inc. (US)
- Repligen Corporation (US)
- Getinge AB (Sweden)
- Eppendorf SE (Germany)
- Parker Hannifin Corporation (US)
- Entegris (US)
- Saint-Gobain (France)
- Corning Incorporated (US)
- Lonza (Switzerland)
- TECNIC Bioprocess Equipment Manufacturing (Spain)
- FUJIMORI KOGYO CO., LTD. (Japan)
- Kühner AG (Switzerland)
- OmniBRx Biotechnologies (India)
- New Horizon Biotechnology, Inc. (US)
- PBS Biotech, Inc. (US)
- bbi-biotech GmbH (Germany)
- ABEC, Inc. (US)
- Esco Lifesciences Group Ltd. (US)
- Distek, Inc. (US)
- SATAKE MultiMix Corporation (Japan)
- Cell Culture Company, LLC (US)
- Micro Digital Co., Ltd. (South Korea)
- Celltainer Biotech B.V. (Netherlands)
- Meissner Filtration Products, Inc. (US)
- Solida Biotech GmbH (Germany)
- G&G Technologies, Inc. (US)
- PharmNXT Biotech (India)
- Tofflon Life Science Co., Ltd. (China)
Research Coverage:
This research report categorizes the single-use bioreactors market by product (single-use bioreactor systems, single-use media bags, single-use assemblies, and other products), by type (stirred-tank single-use bioreactors, wave-induced single-use bioreactors, bubble-column single-use bioreactors, and other single-use bioreactors), by molecule type (monoclonal antibodies (mAbs), vaccines, therapeutic proteins & peptides, stem cells, and cell & gene therapy), by cell type (mammalian cells, bacterial cells, yeast cells, and other cells), by application (bioproduction, process development, and research & development (R&D)), by end user (pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations (CROs & CMOs), and academic & research institutes) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use bioreactors market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the single-use bioreactors market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioreactors market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing adoption among CDMOs, CMOs, and SMEs, advantages over conventional bioreactors, reduced capital investment, reduced water and energy consumption, growing biologics & biosimilars markets), restraints (issues related to extractables & leachables, regulatory hurdles and compliance issues, and, the impact of PFAS restrictions on product development), opportunities (untapped market potential in emerging economies and hybrid facilities), and Challenges (lack of standardization, waste disposal, and potential breakage of SU bags) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the single-use bioreactors market
- Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use bioreactors market
- Competitive Assessment: Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Entegris (US), Getinge AB (Sweden), Parker Hannifin Corporation (US), among others in the market.
Table of Contents
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS & EXCLUSIONS 40
1.3 MARKET SCOPE 41
1.3.1 MARKETS COVERED 41
1.3.2 YEARS CONSIDERED 42
1.3.3 CURRENCY CONSIDERED 42
1.4 STAKEHOLDERS 42
1.5 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
2.1.1 SECONDARY DATA 45
2.1.2 PRIMARY DATA 45
2.2 MARKET ESTIMATION METHODOLOGY 47
2.2.1 MARKET ESTIMATION 47
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 50
2.2.3 TOP-DOWN APPROACH 50
2.3 MARKET GROWTH RATE PROJECTIONS 51
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 53
2.5 RESEARCH ASSUMPTIONS 54
2.6 RESEARCH LIMITATIONS 55
2.7 RISK ANALYSIS 55
2.8 GENERATIVE AI IMPACT ON SINGLE-USE BIOREACTORS MARKET 56
3 EXECUTIVE SUMMARY 57
4 PREMIUM INSIGHTS 62
4.1 SINGLE-USE BIOREACTORS MARKET OVERVIEW 62
4.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION AND COUNTRY (2023) 63
4.3 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024 VS. 2029 63
4.4 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
5.2.1 DRIVERS 67
5.2.1.1 Growing adoption among CDMOs, CMOs, and SMEs 67
5.2.1.2 Advantages over conventional bioreactors 67
5.2.1.3 Reduced capital investment 69
5.2.1.4 Reduced water and energy consumption 70
5.2.1.5 Growing biologics & biosimilars markets 71
5.2.2 RESTRAINTS 72
5.2.2.1 Issues related to extractables & leachables 72
5.2.2.2 Regulatory hurdles and compliance issues 72
5.2.2.3 Impact of PFAS restrictions on product development 73
5.2.3 OPPORTUNITIES 74
5.2.3.1 Untapped market potential in emerging economies 74
5.2.3.2 Hybrid facilities 75
5.2.4 CHALLENGES 75
5.2.4.1 Lack of standardization 75
5.2.4.2 Waste disposal 76
5.2.4.3 Potential breakage of SU bags 77
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.4 PRICING ANALYSIS 78
5.4.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023 79
5.4.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION, 2023 79
5.5 SUPPLY CHAIN ANALYSIS 80
5.6 VALUE CHAIN ANALYSIS 81
5.7 ECOSYSTEM ANALYSIS 83
5.7.1 SINGLE-USE BIOREACTORS MARKET: RAW MATERIAL SUPPLIERS 83
5.7.2 SINGLE-USE BIOREACTORS MARKET: MANUFACTURERS 84
5.7.3 SINGLE-USE BIOREACTORS MARKET: END USERS 85
5.7.4 SINGLE-USE BIOREACTORS MARKET: REGULATORY BODIES 85
5.8 TECHNOLOGY ANALYSIS 86
5.8.1 KEY TECHNOLOGIES 86
5.8.1.1 Fermentation 86
5.8.1.2 Continuous bioprocessing 87
5.8.1.3 3D cell culture 87
5.8.2 COMPLEMENTARY TECHNOLOGIES 88
5.8.3 ADJACENT TECHNOLOGIES 89
5.9 PATENT ANALYSIS 90
5.10 KEY CONFERENCES AND EVENTS IN 2024–2025 92
5.11 REGULATORY LANDSCAPE 92
5.11.1 REGULATORY SCENARIO 93
5.11.1.1 North America 93
5.11.1.1.1 US 93
5.11.1.1.2 Canada 93
5.11.1.2 Europe 93
5.11.1.2.1 Germany 93
5.11.1.2.2 UK 93
5.11.1.3 Asia Pacific 94
5.11.1.3.1 Japan 94
5.11.1.3.2 China 94
5.11.1.4 Latin America 94
5.11.1.4.1 Brazil 94
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.12 INVESTMENT & FUNDING SCENARIO 97
5.13 PORTER’S FIVE FORCES ANALYSIS 97
5.13.1 THREAT OF NEW ENTRANTS 98
5.13.2 THREAT OF SUBSTITUTES 98
5.13.3 BARGAINING POWER OF BUYERS 98
5.13.4 BARGAINING POWER OF SUPPLIERS 99
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 99
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
5.14.2 BUYING CRITERIA FOR END USERS 100
5.15 TRADE ANALYSIS 102
5.16 IMPACT OF GENERATIVE AI ON SINGLE-USE BIOREACTORS MARKET 105
6 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT 106
6.1 INTRODUCTION 107
6.2 SINGLE-USE BIOREACTOR SYSTEMS 107
6.2.1 ≤10 L BIOREACTORS 111
6.2.1.1 Flexibility in early-stage R&D to boost market 111
6.2.2 11–100 L BIOREACTORS 114
6.2.2.1 Scalability for process development to drive demand 114
6.2.3 101–500 L BIOREACTORS 117
6.2.3.1 Efficiency in pilot-scale production to propel demand 117
6.2.4 501–1500 L BIOREACTORS 120
6.2.4.1 Growing use in large-scale commercial production to drive market 120
6.2.5 >1500 L BIOREACTORS 123
6.2.5.1 Rising adoption of single-use technologies in high-demand applications to support market growth 123
6.3 SINGLE-USE MEDIA BAGS 127
6.3.1 2D SINGLE-USE MEDIA BAGS 130
6.3.1.1 Wide use of 2D bags in cell culture applications to drive market growth 130
6.3.2 3D SINGLE-USE MEDIA BAGS 134
6.3.2.1 Usage in large-volume applications to drive market growth 134
6.3.3 OTHER SINGLE-USE MEDIA BAGS 137
6.4 SINGLE-USE ASSEMBLIES 140
6.4.1 OPERATIONAL EFFICIENCY AND FLEXIBILITY TO PROPEL DEMAND FOR SINGLE-USE ASSEMBLIES 140
6.5 OTHER PRODUCTS 143
7 SINGLE-USE BIOREACTORS MARKET, BY TYPE 147
7.1 INTRODUCTION 148
7.2 STIRRED-TANK SINGLE-USE BIOREACTORS 148
7.2.1 GROWING PREFERENCE FOR AEROBIC MICROBIAL CELL CULTURES TO SUPPORT MARKET GROWTH 148
7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 152
7.3.1 GROWING ADOPTION FOR SHEAR STRESS-SENSITIVE CELL LINES TO FUEL GROWTH 152
7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 156
7.4.1 EFFICIENT MASS AND HEAT TRANSFER CAPABILITY TO DRIVE GROWTH 156
7.5 OTHER SINGLE-USE BIOREACTORS 159
8 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE 163
8.1 INTRODUCTION 164
8.2 MONOCLONAL ANTIBODIES 164
8.2.1 GROWING FOCUS ON THERAPEUTIC APPLICATIONS TO DRIVE DEMAND FOR SINGLE-USE BIOREACTORS 164
8.3 VACCINES 168
8.3.1 USE OF SINGLE-USE SYSTEMS FOR VACCINE PRODUCTION TO BOOST MARKET GROWTH 168
8.4 THERAPEUTIC PROTEINS & PEPTIDES 172
8.4.1 ABILITY OF SINGLE-USE TECHNOLOGIES TO HELP MINIMIZE CROSS-CONTAMINATION RISK TO BOOST ADOPTION 172
8.5 STEM CELLS 175
8.5.1 GROWING RESEARCH AND COMMERCIALIZATION OF STEM CELL THERAPIES TO DRIVE MARKET 175
8.6 CELL & GENE THERAPY 178
8.6.1 INCREASING RESEARCH INITIATIVES FOR GENE AND CELL THERAPIES TO DRIVE MARKET 178
9 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE 182
9.1 INTRODUCTION 183
9.2 MAMMALIAN CELLS 183
9.2.1 GROWING USE OF MAMMALIAN CELLS IN PRODUCTION OF MONOCLONAL ANTIBODIES TO DRIVE MARKET 183
9.3 BACTERIAL CELLS 187
9.3.1 GROWING ADOPTION IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION TO DRIVE MARKET 187
9.4 YEAST CELLS 190
9.4.1 HIGH GROWTH RATE AND MINIMAL MEDIA CONDITIONS TO DRIVE ADOPTION IN RECOMBINANT PROTEIN PRODUCTION 190
9.5 OTHER CELLS 193
10 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION 196
10.1 INTRODUCTION 197
10.2 BIOPRODUCTION 197
10.2.1 INCREASING BIOPHARMACEUTICAL PRODUCTION TO DRIVE DEMAND FOR COST-EFFECTIVE SINGLE-USE BIOREACTORS 197
10.3 PROCESS DEVELOPMENT 202
10.3.1 ACCELERATED TIME-TO-MARKET TO PROPEL ADOPTION 202
10.4 RESEARCH & DEVELOPMENT 206
10.4.1 RISING ADOPTION OF SINGLE-USE BIOREACTORS FOR COST-EFFECTIVENESS TO DRIVE MARKET 206
11 SINGLE-USE BIOREACTORS MARKET, BY END USER 210
11.1 INTRODUCTION 211
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 211
11.2.1 GROWING BIOLOGICS AND BIOSIMILARS MARKET TO INCREASE DEMAND FOR SINGLE-USE BIOREACTORS 211
11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 215
11.3.1 INCREASING OUTSOURCING OF R&D AND MANUFACTURING TO SUPPORT MARKET GROWTH 215
11.4 ACADEMIC & RESEARCH INSTITUTES 218
11.4.1 COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET 218
12 SINGLE-USE BIOREACTORS MARKET, BY REGION 222
12.1 INTRODUCTION 223
12.2 NORTH AMERICA 223
12.2.1 US 228
12.2.1.1 US to dominate North American market during study period 228
12.2.2 CANADA 233
12.2.2.1 Increasing government support for biologics manufacturing and rising research funding to propel market growth 233
12.3 EUROPE 237
12.3.1 GERMANY 241
12.3.1.1 High government R&D investment and technological advancements to aid market growth 241
12.3.2 UK 245
12.3.2.1 Increased government funding for pharmaceutical & biotechnology research to boost market growth 245
12.3.3 FRANCE 249
12.3.3.1 Favorable government initiatives and increased investments by foreign pharmaceutical companies to augment market growth 249
12.3.4 ITALY 253
12.3.4.1 Increasing government grants for biopharmaceutical and life science research to support market 253
12.3.5 SPAIN 257
12.3.5.1 Rising focus on personalized medicine to fuel market growth 257
12.3.6 REST OF EUROPE 261
12.4 ASIA PACIFIC 265
12.4.1 CHINA 270
12.4.1.1 Low manufacturing costs and high investments in biotechnology sector to spur market growth 270
12.4.2 SOUTH KOREA 274
12.4.2.1 Increased focus on quality manufacturing practices to aid market growth 274
12.4.3 JAPAN 278
12.4.3.1 Increasing collaborations among biotechnology companies to drive market 278
12.4.4 INDIA 282
12.4.4.1 High foreign direct investments and favorable government policies to propel market growth 282
12.4.5 AUSTRALIA 286
12.4.5.1 Increased demand for innovative research solutions and developed pharmaceutical industry to support market growth 286
12.4.6 REST OF ASIA PACIFIC 290
12.5 LATIN AMERICA 294
12.5.1 BRAZIL 298
12.5.1.1 Increasing pharmaceutical R&D to fuel market growth 298
12.5.2 MEXICO 302
12.5.2.1 Increased foreign direct investment from US and reduced pharmaceutical manufacturing costs to boost market growth 302
12.5.3 REST OF LATIN AMERICA 306
12.6 MIDDLE EAST 310
12.6.1 GCC COUNTRIES 314
12.6.1.1 Saudi Arabia 318
12.6.1.1.1 Rising healthcare expenditure to boost market growth 318
12.6.1.2 UAE 322
12.6.1.2.1 Increasing collaborations among biopharma companies to aid market growth 322
12.6.1.3 Rest of GCC countries 326
12.6.2 REST OF MIDDLE EAST 330
12.7 AFRICA 334
12.7.1 INCREASING DEMAND FOR DRUGS AND GROWING PATIENT POOL TO PROPEL MARKET GROWTH 334
13 COMPETITIVE LANDSCAPE 338
13.1 OVERVIEW 338
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 338
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE BIOREACTORS MARKET 339
13.3 REVENUE ANALYSIS 340
13.4 MARKET SHARE ANALYSIS 341
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 343
13.5.1 STARS 343
13.5.2 EMERGING LEADERS 343
13.5.3 PERVASIVE PLAYERS 343
13.5.4 PARTICIPANTS 343
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 345
13.5.5.1 Company footprint 345
13.5.5.2 Region footprint 346
13.5.5.3 Product footprint 347
13.5.5.4 Application footprint 348
13.5.5.5 End-user footprint 349
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 350
13.6.1 PROGRESSIVE COMPANIES 350
13.6.2 RESPONSIVE COMPANIES 350
13.6.3 DYNAMIC COMPANIES 350
13.6.4 STARTING BLOCKS 350
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 352
13.7 COMPANY VALUATION AND FINANCIAL METRICS 354
13.7.1 FINANCIAL METRICS 354
13.7.2 COMPANY VALUATION 355
13.8 BRAND/PRODUCT COMPARISON 355
13.9 COMPETITIVE SCENARIO 356
13.9.1 PRODUCT LAUNCHES 356
13.9.2 DEALS 357
13.9.3 EXPANSIONS 358
14 COMPANY PROFILES 359
14.1 KEY PLAYERS 359
14.1.1 SARTORIUS AG 359
14.1.1.1 Business overview 359
14.1.1.2 Products offered 360
14.1.1.3 Recent developments 362
14.1.1.3.1 Product launches 362
14.1.1.3.2 Deals 362
14.1.1.3.3 Expansions 363
14.1.1.4 MnM view 363
14.1.1.4.1 Key strengths 363
14.1.1.4.2 Strategic choices 364
14.1.1.4.3 Weaknesses and competitive threats 364
14.1.2 DANAHER CORPORATION 365
14.1.2.1 Business overview 365
14.1.2.2 Products offered 367
14.1.2.3 Recent developments 369
14.1.2.3.1 Deals 369
14.1.2.3.2 Expansions 370
14.1.2.4 MnM view 371
14.1.2.4.1 Right to win 371
14.1.2.4.2 Strategic choices 371
14.1.2.4.3 Weaknesses and competitive threats 371
14.1.3 THERMO FISHER SCIENTIFIC INC. 372
14.1.3.1 Business overview 372
14.1.3.2 Products offered 374
14.1.3.3 Recent developments 375
14.1.3.3.1 Deals 375
14.1.3.3.2 Expansions 376
14.1.3.4 MnM view 377
14.1.3.4.1 Right to win 377
14.1.3.4.2 Strategic choices 377
14.1.3.4.3 Weaknesses and competitive threats 377
14.1.4 MERCK KGAA 378
14.1.4.1 Business overview 378
14.1.4.2 Products offered 379
14.1.4.3 Recent developments 380
14.1.4.3.1 Product launches 380
14.1.4.3.2 Deals 381
14.1.4.3.3 Expansions 381
14.1.4.4 MnM view 382
14.1.4.4.1 Right to win 382
14.1.4.4.2 Strategic choices 382
14.1.4.4.3 Weaknesses and competitive threats 382
14.1.5 AVANTOR, INC. 383
14.1.5.1 Business overview 383
14.1.5.2 Products offered 384
14.1.5.3 Recent developments 385
14.1.5.3.1 Deals 385
14.1.5.3.2 Expansions 386
14.1.6 REPLIGEN CORPORATION 387
14.1.6.1 Business overview 387
14.1.6.2 Products offered 389
14.1.6.3 Recent developments 390
14.1.6.3.1 Deals 390
14.1.6.3.2 Expansions 390
14.1.7 GETINGE AB 391
14.1.7.1 Business overview 391
14.1.7.2 Products offered 392
14.1.7.3 Recent developments 393
14.1.7.3.1 Product launches 393
14.1.7.3.2 Deals 394
14.1.7.3.3 Expansions 394
14.1.8 EPPENDORF SE 395
14.1.8.1 Business overview 395
14.1.8.2 Products offered 396
14.1.8.3 Recent developments 397
14.1.8.3.1 Product launches 397
14.1.9 PARKER HANNIFIN CORPORATION 398
14.1.9.1 Business overview 398
14.1.9.2 Products offered 400
14.1.10 ENTEGRIS 401
14.1.10.1 Business overview 401
14.1.10.2 Products offered 402
14.1.10.3 Recent developments 403
14.1.10.3.1 Expansions 403
14.1.11 SAINT-GOBAIN 404
14.1.11.1 Business overview 404
14.1.11.2 Products offered 405
14.1.11.3 Recent developments 406
14.1.11.3.1 Deals 406
14.1.11.3.2 Expansions 406
14.1.12 CORNING INCORPORATED 407
14.1.12.1 Business overview 407
14.1.12.2 Products offered 409
14.1.13 LONZA 410
14.1.13.1 Business overview 410
14.1.13.2 Products offered 411
14.1.14 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING 412
14.1.14.1 Business overview 412
14.1.14.2 Products offered 412
14.1.14.3 Recent developments 413
14.1.14.3.1 Product launches 413
14.1.14.3.2 Deals 413
14.1.14.3.3 Expansions 414
14.1.15 FUJIMORI KOGYO CO., LTD. 415
14.1.15.1 Business overview 415
14.1.15.2 Products offered 416
14.1.15.3 Recent developments 416
14.1.15.3.1 Expansions 416
14.2 OTHER PLAYERS 417
14.2.1 KÜHNER AG 417
14.2.2 OMNIBRX BIOTECHNOLOGIES 418
14.2.3 NEW HORIZON BIOTECHNOLOGY, INC. 419
14.2.4 PBS BIOTECH, INC. 420
14.2.5 BBI-BIOTECH GMBH 421
14.2.6 ABEC, INC. 422
14.2.7 ESCO LIFESCIENCES GROUP LTD. 423
14.2.8 DISTEK, INC. 424
14.2.9 SATAKE MULTIMIX CORPORATION 425
14.2.10 CELL CULTURE COMPANY, LLC 426
14.2.11 MICRO DIGITAL CO., LTD. 427
14.2.12 CELLTAINER BIOTECH B.V. 428
14.2.13 MEISSNER FILTRATION PRODUCTS, INC. 429
14.2.14 SOLIDA BIOTECH GMBH 430
14.2.15 G&G TECHNOLOGIES, INC. 431
14.2.16 PHARMNXT BIOTECH 432
14.2.17 TOFFLON LIFE SCIENCE CO., LTD. 432
14.2.18 SHANGHAI LEPURE BIOTECH CO., LTD. 433
15 APPENDIX 434
15.1 DISCUSSION GUIDE 434
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 438
15.3 CUSTOMIZATION OPTIONS 440
15.4 RELATED REPORTS 441
15.5 AUTHOR DETAILS 442
LIST OF TABLES
TABLE 1 SINGLE-USE BIOREACTORS MARKET: INCLUSIONS & EXCLUSIONS 40
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 52
TABLE 3 SINGLE-USE BIOREACTORS MARKET: RISK ASSESSMENT ANALYSIS 55
TABLE 4 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS 66
TABLE 5 COMPARISON OF SINGLE-USE AND MULTIUSE BIOREACTORS 68
TABLE 6 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS (COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE) 71
TABLE 7 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS 76
TABLE 8 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS 76
TABLE 9 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYERS, 2023 79
TABLE 10 INDICATIVE PRICING ANALYSIS OF SINGLE-USE BIOREACTORS, BY REGION, 2023 79
TABLE 11 SINGLE-USE BIOREACTORS MARKET: RAW MATERIAL SUPPLIERS 84
TABLE 12 SINGLE-USE BIOREACTORS MARKET: MANUFACTURERS 84
TABLE 13 SINGLE-USE BIOREACTORS MARKET: END USERS 85
TABLE 14 SINGLE-USE BIOREACTORS MARKET: REGULATORY BODIES 86
TABLE 15 SINGLE-USE BIOREACTORS: COMPLEMENTARY TECHNOLOGIES 88
TABLE 16 SINGLE-USE BIOREACTORS: ADJACENT TECHNOLOGIES 89
TABLE 17 KEY PATENTS IN SINGLE-USE BIOREACTORS MARKET 91
TABLE 18 SINGLE-USE BIOREACTORS MARKET: CONFERENCES AND EVENTS, 2024–2025 92
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 96
TABLE 23 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 96
TABLE 24 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 97
TABLE 25 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS, BY END USER 101
TABLE 26 IMPORT VALUE FOR HS CODE 841989, 2019–2023 (USD THOUSAND) 102
TABLE 27 EXPORT VALUE FOR HS CODE 841989, 2019–2023 (USD THOUSAND) 103
TABLE 28 IMPORT VOLUME FOR HS CODE 841989, 2019–2023 (TONS) 103
TABLE 29 EXPORT VOLUME FOR HS CODE 841989, 2019–2023 (TONS) 104
TABLE 30 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 107
TABLE 31 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS OFFERED BY MARKET PLAYERS 108
TABLE 32 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE,
2022–2029 (USD MILLION) 108
TABLE 33 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 108
TABLE 34 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 35 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 36 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 110
TABLE 37 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 38 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 110
TABLE 39 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 40 ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 111
TABLE 41 NORTH AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 42 EUROPE: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 43 ASIA PACIFIC: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 44 LATIN AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 45 MIDDLE EAST: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 46 GCC COUNTRIES: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 47 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 114
TABLE 48 NORTH AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 49 EUROPE: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 50 ASIA PACIFIC: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 51 LATIN AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 52 MIDDLE EAST: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 53 GCC COUNTRIES: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 54 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 117
TABLE 55 NORTH AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 56 EUROPE: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 57 ASIA PACIFIC: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 58 LATIN AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 59 MIDDLE EAST: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 60 GCC COUNTRIES: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 61 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 120
TABLE 62 NORTH AMERICA: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 63 EUROPE: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 64 ASIA PACIFIC: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 65 LATIN AMERICA: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 66 MIDDLE EAST: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 67 GCC COUNTRIES: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 68 >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 124
TABLE 69 NORTH AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 70 EUROPE: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 71 ASIA PACIFIC: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 72 LATIN AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 73 MIDDLE EAST: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 74 GCC COUNTRIES: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 75 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 127
TABLE 76 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION) 128
TABLE 77 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 128
TABLE 78 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 128
TABLE 79 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 80 LATIN AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 81 MIDDLE EAST: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 82 GCC COUNTRIES: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 130
TABLE 83 2D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 84 NORTH AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 131
TABLE 85 EUROPE: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 132
TABLE 86 ASIA PACIFIC: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 132
TABLE 87 LATIN AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 88 MIDDLE EAST: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 89 GCC COUNTRIES: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 90 3D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION) 134
TABLE 91 NORTH AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 135
TABLE 92 EUROPE: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 135
TABLE 93 ASIA PACIFIC: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 94 LATIN AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 95 MIDDLE EAST: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 96 GCC COUNTRIES: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 137
TABLE 97 OTHER SINGLE-USE MEDIA BAGS MARKET, BY REGION,
2022–2029 (USD MILLION) 137
TABLE 98 NORTH AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 99 EUROPE: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 100 ASIA PACIFIC: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 139
TABLE 101 LATIN AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 139
TABLE 102 MIDDLE EAST: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 139
TABLE 103 GCC COUNTRIES: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 104 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 105 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 141
TABLE 106 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 141
TABLE 107 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 142
TABLE 108 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 142
TABLE 109 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 142
TABLE 110 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 143
TABLE 111 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION,
2022–2029 (USD MILLION) 144
TABLE 112 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 113 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 114 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 115 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 116 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 117 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 118 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 148
TABLE 119 EXAMPLES OF SINGLE-USE STIRRED-TANK BIOREACTOR SYSTEMS FOR
STEM CELL CULTURE 149
TABLE 120 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION,
2022–2029 (USD MILLION) 149
TABLE 121 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 122 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 123 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 124 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 125 MIDDLE EAST: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 126 GCC COUNTRIES: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 127 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION,
2022–2029 (USD MILLION) 153
TABLE 128 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 129 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 130 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 131 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 132 MIDDLE EAST: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 133 GCC COUNTRIES: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 134 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION,
2022–2029 (USD MILLION) 156
TABLE 135 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 136 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 137 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 138 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 139 MIDDLE EAST: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 140 GCC COUNTRIES: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 141 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION,
2022–2029 (USD MILLION) 159
TABLE 142 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 143 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 160
TABLE 144 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 161
TABLE 145 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 161
TABLE 146 MIDDLE EAST: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 161
TABLE 147 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 148 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 164
TABLE 149 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 150 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 151 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES,
BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 152 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 153 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 154 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 155 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 156 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION,
2022–2029 (USD MILLION) 169
TABLE 157 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 158 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 159 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 160 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 161 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 162 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR VACCINES,
BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 163 SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES,
BY REGION, 2022–2029 (USD MILLION) 172
TABLE 164 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 165 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 166 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 167 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 168 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 169 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 170 SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY REGION,
2022–2029 (USD MILLION) 176
TABLE 171 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 172 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 173 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 174 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 175 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 176 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION) 179
TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 179 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 180 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY,
BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 181 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 182 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 183 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 184 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 183
TABLE 185 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION,
2022–2029 (USD MILLION) 184
TABLE 186 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 187 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 188 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 189 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 190 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 191 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 192 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION,
2022–2029 (USD MILLION) 187
TABLE 193 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 194 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 195 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 196 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 197 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 198 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 199 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION,
2022–2029 (USD MILLION) 190
TABLE 200 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 201 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 202 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 203 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 204 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 205 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 206 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION,
2022–2029 (USD MILLION) 193
TABLE 207 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 209 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 210 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 211 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 212 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 213 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 197
TABLE 214 US: NUMBER OF PRODUCTS GOING OFF-PATENT, 2023–2028 198
TABLE 215 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION,
2022–2029 (USD MILLION) 199
TABLE 216 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 217 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 218 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 219 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 220 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY REGION, 2022–2029 (USD MILLION) 201
TABLE 221 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION,
BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 222 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 223 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 224 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT,
BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 225 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 226 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 227 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 205
TABLE 228 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 229 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT,
BY REGION, 2022–2029 (USD MILLION) 207
TABLE 230 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 231 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 232 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 233 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 234 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 208
TABLE 235 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 236 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 211
TABLE 237 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 212
TABLE 238 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 239 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 240 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 241 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 242 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 214
TABLE 243 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 244 SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION,
2022–2029 (USD MILLION) 215
TABLE 245 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 246 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 247 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 248 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 249 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY REGION, 2022–2029 (USD MILLION) 217
TABLE 250 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 251 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2022–2029 (USD MILLION) 219
TABLE 252 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 253 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 220
TABLE 254 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 220
TABLE 255 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 256 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 221
TABLE 257 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 258 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 223
TABLE 259 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 224
TABLE 260 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 225
TABLE 261 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 225
TABLE 262 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 263 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 226
TABLE 264 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 227
TABLE 265 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 227
TABLE 266 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 227
TABLE 267 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 228
TABLE 268 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 229
TABLE 269 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 230
TABLE 270 US: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 230
TABLE 271 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 272 US: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 231
TABLE 273 US: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 232
TABLE 274 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 232
TABLE 275 US: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 232
TABLE 276 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 233
TABLE 277 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 234
TABLE 278 CANADA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 234
TABLE 279 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 235
TABLE 280 CANADA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 235
TABLE 281 CANADA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 236
TABLE 282 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 236
TABLE 283 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 236
TABLE 284 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 237
TABLE 285 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 238
TABLE 286 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 287 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 288 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 239
TABLE 289 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 239
TABLE 290 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 240
TABLE 291 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 240
TABLE 292 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 240
TABLE 293 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 241
TABLE 294 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 242
TABLE 295 GERMANY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 242
TABLE 296 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 243
TABLE 297 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 243
TABLE 298 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 244
TABLE 299 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 244
TABLE 300 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 244
TABLE 301 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 245
TABLE 302 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 246
TABLE 303 UK: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 246
TABLE 304 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 305 UK: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 247
TABLE 306 UK: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 248
TABLE 307 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 248
TABLE 308 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 248
TABLE 309 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 249
TABLE 310 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 250
TABLE 311 FRANCE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 250
TABLE 312 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 251
TABLE 313 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 251
TABLE 314 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 252
TABLE 315 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 252
TABLE 316 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 252
TABLE 317 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 253
TABLE 318 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 254
TABLE 319 ITALY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 254
TABLE 320 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 321 ITALY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 255
TABLE 322 ITALY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 256
TABLE 323 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 256
TABLE 324 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 256
TABLE 325 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 257
TABLE 326 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 258
TABLE 327 SPAIN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 258
TABLE 328 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 329 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 259
TABLE 330 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 260
TABLE 331 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 260
TABLE 332 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 260
TABLE 333 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 261
TABLE 334 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 262
TABLE 335 REST OF EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 336 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 263
TABLE 337 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 263
TABLE 338 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 264
TABLE 339 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 264
TABLE 340 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 264
TABLE 341 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 266
TABLE 342 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 266
TABLE 343 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 267
TABLE 344 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 267
TABLE 345 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 268
TABLE 346 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 268
TABLE 347 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 269
TABLE 348 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 269
TABLE 349 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 269
TABLE 350 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 271
TABLE 351 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 271
TABLE 352 CHINA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 272
TABLE 353 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 272
TABLE 354 CHINA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 273
TABLE 355 CHINA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 273
TABLE 356 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 273
TABLE 357 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 274
TABLE 358 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 275
TABLE 359 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 275
TABLE 360 SOUTH KOREA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 276
TABLE 361 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 276
TABLE 362 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 277
TABLE 363 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 277
TABLE 364 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 278
TABLE 365 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 278
TABLE 366 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 279
TABLE 367 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 279
TABLE 368 JAPAN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 280
TABLE 369 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 370 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 281
TABLE 371 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 281
TABLE 372 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 281
TABLE 373 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 282
TABLE 374 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 283
TABLE 375 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 283
TABLE 376 INDIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 284
TABLE 377 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 284
TABLE 378 INDIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 285
TABLE 379 INDIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 285
TABLE 380 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 285
TABLE 381 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 286
TABLE 382 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 287
TABLE 383 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 287
TABLE 384 AUSTRALIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 288
TABLE 385 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 288
TABLE 386 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 289
TABLE 387 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 289
TABLE 388 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 290
TABLE 389 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 290
TABLE 390 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 291
TABLE 391 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 392 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 393 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 292
TABLE 394 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 293
TABLE 395 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 293
TABLE 396 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 293
TABLE 397 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 294
TABLE 398 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 294
TABLE 399 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 295
TABLE 400 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 295
TABLE 401 LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 296
TABLE 402 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 296
TABLE 403 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 297
TABLE 404 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 297
TABLE 405 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 297
TABLE 406 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 298
TABLE 407 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 299
TABLE 408 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 299
TABLE 409 BRAZIL: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 300
TABLE 410 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 300
TABLE 411 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 301
TABLE 412 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 301
TABLE 413 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 301
TABLE 414 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 302
TABLE 415 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 303
TABLE 416 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 303
TABLE 417 MEXICO: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 303
TABLE 418 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 304
TABLE 419 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 304
TABLE 420 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 305
TABLE 421 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 305
TABLE 422 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 305
TABLE 423 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 306
TABLE 424 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 307
TABLE 425 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 307
TABLE 426 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 308
TABLE 427 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 308
TABLE 428 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 309
TABLE 429 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 309
TABLE 430 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 309
TABLE 431 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION,
2022–2029 (USD MILLION) 310
TABLE 432 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 310
TABLE 433 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 311
TABLE 434 MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 311
TABLE 435 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 312
TABLE 436 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 312
TABLE 437 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 313
TABLE 438 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 313
TABLE 439 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 313
TABLE 440 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 314
TABLE 441 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 314
TABLE 442 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 315
TABLE 443 GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 315
TABLE 444 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 316
TABLE 445 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 316
TABLE 446 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 317
TABLE 447 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 317
TABLE 448 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 317
TABLE 449 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 318
TABLE 450 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 319
TABLE 451 SAUDI ARABIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 319
TABLE 452 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 320
TABLE 453 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 320
TABLE 454 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 321
TABLE 455 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 321
TABLE 456 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 321
TABLE 457 UAE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 322
TABLE 458 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 323
TABLE 459 UAE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 323
TABLE 460 UAE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 324
TABLE 461 UAE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 324
TABLE 462 UAE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 325
TABLE 463 UAE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 325
TABLE 464 UAE: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 325
TABLE 465 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 326
TABLE 466 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 327
TABLE 467 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 327
TABLE 468 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 328
TABLE 469 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 328
TABLE 470 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 329
TABLE 471 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 329
TABLE 472 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 329
TABLE 473 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 330
TABLE 474 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 331
TABLE 475 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 331
TABLE 476 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 332
TABLE 477 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION) 332
TABLE 478 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 333
TABLE 479 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 333
TABLE 480 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 333
TABLE 481 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 334
TABLE 482 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 483 AFRICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 484 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE,
2022–2029 (USD MILLION) 336
TABLE 485 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2022–2029 (USD MILLION) 336
TABLE 486 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 337
TABLE 487 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 337
TABLE 488 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER,
2022–2029 (USD MILLION) 337
TABLE 489 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES, 2021−2024 339
TABLE 490 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION 342
TABLE 491 SINGLE-USE BIOREACTORS MARKET: REGION FOOTPRINT 346
TABLE 492 SINGLE-USE BIOREACTORS MARKET: PRODUCT FOOTPRINT 347
TABLE 493 SINGLE-USE BIOREACTORS MARKET: APPLICATION FOOTPRINT 348
TABLE 494 SINGLE-USE BIOREACTORS MARKET: END-USER FOOTPRINT 349
TABLE 495 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 352
TABLE 496 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 353
TABLE 497 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES,
JANUARY 2021–JUNE 2024 356
TABLE 498 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2021–JUNE 2024 357
TABLE 499 SINGLE-USE BIOREACTORS MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024 358
TABLE 500 SARTORIUS AG: COMPANY OVERVIEW 359
TABLE 501 SARTORIUS AG: PRODUCTS OFFERED 360
TABLE 502 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 362
TABLE 503 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024 362
TABLE 504 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2024 363
TABLE 505 DANAHER CORPORATION: COMPANY OVERVIEW 365
TABLE 506 DANAHER CORPORATION: PRODUCTS OFFERED 367
TABLE 507 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024 369
TABLE 508 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2024 370
TABLE 509 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 372
TABLE 510 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 374
TABLE 511 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024 375
TABLE 512 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 376
TABLE 513 MERCK KGAA: COMPANY OVERVIEW 378
TABLE 514 MERCK KGAA: PRODUCTS OFFERED 379
TABLE 515 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 380
TABLE 516 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024 381
TABLE 517 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024 381
TABLE 518 AVANTOR, INC.: COMPANY OVERVIEW 383
TABLE 519 AVANTOR, INC.: PRODUCTS OFFERED 384
TABLE 520 AVANTOR, INC.: DEALS, JANUARY 2021–JUNE 2024 385
TABLE 521 AVANTOR, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 386
TABLE 522 REPLIGEN CORPORATION: COMPANY OVERVIEW 387
TABLE 523 REPLIGEN CORPORATION: PRODUCTS OFFERED 389
TABLE 524 REPLIGEN CORPORATION: DEALS, JANUARY 2021–JUNE 2024 390
TABLE 525 REPLIGEN CORPORATION: EXPANSION, JANUARY 2021–JUNE 2024 390
TABLE 526 GETINGE AB: COMPANY OVERVIEW 391
TABLE 527 GETINGE AB: PRODUCTS OFFERED 392
TABLE 528 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 393
TABLE 529 GETINGE AB: DEALS, JANUARY 2021–JUNE 2024 394
TABLE 530 GETINGE AB: EXPANSIONS, JANUARY 2021–JUNE 2024 394
TABLE 531 EPPENDORF SE: COMPANY OVERVIEW 395
TABLE 532 EPPENDORF SE: PRODUCTS OFFERED 396
TABLE 533 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 397
TABLE 534 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW 398
TABLE 535 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 400
TABLE 536 ENTEGRIS: COMPANY OVERVIEW 401
TABLE 537 ENTEGRIS: PRODUCTS OFFERED 402
TABLE 538 ENTEGRIS: EXPANSION, JANUARY 2021–JUNE 2024 403
TABLE 539 SAINT-GOBAIN: COMPANY OVERVIEW 404
TABLE 540 SAINT-GOBAIN: PRODUCTS OFFERED 405
TABLE 541 SAINT-GOBAIN: DEALS, JANUARY 2021–JUNE 2024 406
TABLE 542 SAINT-GOBAIN: EXPANSIONS, JANUARY 2021–JUNE 2024 406
TABLE 543 CORNING INCORPORATED: COMPANY OVERVIEW 407
TABLE 544 CORNING INCORPORATED: PRODUCTS OFFERED 409
TABLE 545 LONZA: COMPANY OVERVIEW 410
TABLE 546 LONZA: PRODUCTS OFFERED 411
TABLE 547 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY OVERVIEW 412
TABLE 548 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCTS OFFERED 412
TABLE 549 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 413
TABLE 550 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: DEALS,
JANUARY 2021–JUNE 2024 413
TABLE 551 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: EXPANSIONS, JANUARY 2021–JUNE 2024 414
TABLE 552 FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW 415
TABLE 553 FUJIMORI KOGYO CO., LTD.: PRODUCTS OFFERED 416
TABLE 554 FUJIMORI KOGYO CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2024 416
TABLE 555 KUHNER AG: COMPANY OVERVIEW 417
TABLE 556 OMNIBRX BIOTECHNOLOGIES: COMPANY OVERVIEW 418
TABLE 557 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 419
TABLE 558 PBS BIOTECH, INC.: COMPANY OVERVIEW 420
TABLE 559 BBI-BIOTECH GMBH: COMPANY OVERVIEW 421
TABLE 560 ABEC, INC.: COMPANY OVERVIEW 422
TABLE 561 ESCO LIFESCIENCES GROUP LTD.: COMPANY OVERVIEW 423
TABLE 562 DISTEK, INC.: COMPANY OVERVIEW 424
TABLE 563 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW 425
TABLE 564 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW 426
TABLE 565 MICRO DIGITAL CO., LTD.: COMPANY OVERVIEW 427
TABLE 566 CELLTAINER BIOTECH B.V.: COMPANY OVERVIEW 428
TABLE 567 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 429
TABLE 568 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW 430
TABLE 569 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW 431
TABLE 570 PHARMNXT BIOTECH: COMPANY OVERVIEW 432
TABLE 571 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW 432
TABLE 572 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW 433
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 44
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOREACTORS MARKET 46
FIGURE 3 SINGLE-USE BIOREACTORS MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2023 47
FIGURE 4 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 48
FIGURE 5 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE SHARE ANALYSIS (2023) 48
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 50
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 50
FIGURE 8 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS 52
FIGURE 9 DATA TRIANGULATION METHODOLOGY 54
FIGURE 10 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 57
FIGURE 11 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 58
FIGURE 12 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE,
2024 VS. 2029 (USD MILLION) 58
FIGURE 13 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE,
2024 VS. 2029 (USD MILLION) 59
FIGURE 14 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 60
FIGURE 15 SINGLE-USE BIOREACTORS MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 60
FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINGLE-USE BIOREACTORS MARKET 61
FIGURE 17 RISING DEMAND FOR BIOLOGICS AND ADVANTAGES OF SUBS OVER CONVENTIONAL BIOREACTORS ARE EXPECTED TO PROPEL MARKET 62
FIGURE 18 BIOPRODUCTION APPLICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 63
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63
FIGURE 20 CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 64
FIGURE 21 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
FIGURE 22 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS.
MULTI-PRODUCT FACILITY 69
FIGURE 23 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS.
MULTI-PRODUCT FACILITY 70
FIGURE 24 BIOSIMILAR APPROVALS & LAUNCHES, 2015–2023 71
FIGURE 25 REVENUE SHIFTS IN SINGLE-USE BIOREACTORS MARKET 78
FIGURE 26 SINGLE-USE BIOREACTORS MARKET: SUPPLY CHAIN ANALYSIS 80
FIGURE 27 SINGLE-USE BIOREACTORS MARKET: VALUE CHAIN ANALYSIS 81
FIGURE 28 SINGLE-USE BIOREACTORS MARKET: ECOSYSTEM 83
FIGURE 29 NUMBER OF PATENTS GRANTED, 2014–2024 90
FIGURE 30 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 98
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTORS PRODUCTS 99
FIGURE 32 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS AMONG END USERS 100
FIGURE 33 PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION) 206
FIGURE 34 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 224
FIGURE 35 US: FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2014–2024 229
FIGURE 36 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 265
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2019–2023 340
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 341
FIGURE 39 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 344
FIGURE 40 SINGLE-USE BIOREACTORS MARKET: COMPANY FOOTPRINT 345
FIGURE 41 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 351
FIGURE 42 EV/EBITDA OF KEY VENDORS 354
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 355
FIGURE 44 SINGLE-USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARISON 355
FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2023) 360
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 366
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 373
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2023) 379
FIGURE 49 AVANTOR, INC.: COMPANY SNAPSHOT (2023) 384
FIGURE 50 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023) 388
FIGURE 51 GETINGE AB: COMPANY SNAPSHOT (2023) 392
FIGURE 52 EPPENDORF SE: COMPANY SNAPSHOT (2023) 396
FIGURE 53 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023) 399
FIGURE 54 ENTEGRIS: COMPANY SNAPSHOT (2023) 402
FIGURE 55 SAINT-GOBAIN: COMPANY SNAPSHOT (2023) 404
FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 408
FIGURE 57 LONZA: COMPANY SNAPSHOT (2023) 411
FIGURE 58 FUJIMORI KOGYO CO., LTD.: COMPANY SNAPSHOT (2023) 415
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11